These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8373254)

  • 1. [A case report of malignant pseudomyxoma peritonei treated by a new modality of intraperitoneal chemo-hyperthermia].
    Kishimoto S; Kameyama M; Kodama K; Nakamori S; Ohigashi H; Hiratsuka M; Sasaki Y; Ishikawa O; Kabuto T; Furukawa H
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1703-6. PubMed ID: 8373254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraperitoneal administration of a combined CDDP, 5-FU and MMC therapy for pseudomyxoma peritonei].
    Sasaki A; Terashima M; Okamoto K; Ikeda K; Takagane A; Takiyama I; Shimada Y; Yamamoto M; Nakajima J; Sasaki N; Saito K
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1828-31. PubMed ID: 10560405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Two cases of pseudomyxoma peritonei that responded to intraperitoneal administrations of a combined CDDP, 5-FU and MMC therapy].
    Sasaki A; Terashima M; Okamoto K; Ikeda K; Takagane A; Takiyama I; Kuboi M; Sasaki N; Saito K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1571-4. PubMed ID: 8854808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
    Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm.
    Murphy EM; Sexton R; Moran BJ
    Dis Colon Rectum; 2007 Jan; 50(1):37-42. PubMed ID: 17115339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomyxoma peritonei syndrome of appendiceal origin: an overview.
    Brueggen C; Baird G; Meisheid A
    Clin J Oncol Nurs; 2007 Aug; 11(4):525-32. PubMed ID: 17723965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on 'Survival of patients with pseudomyxoma peritonei treated by serial debulking'.
    Moran BJ
    Colorectal Dis; 2010 Sep; 12(9):872-3. PubMed ID: 20718839
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
    Hosch WP; Rudi J; Stremmel W
    Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei.
    Cole KL; Choudry HA; Jones HL; Goodell PP; Bartlett DL
    J Surg Oncol; 2012 Sep; 106(4):513-6. PubMed ID: 22396067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
    Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three cases of Pseudomyxoma peritonei treated with intraperitoneal inoculation of cisplatin through an implantable port system].
    Suzuki T; Umekita N; Inoue S; Miyamoto S; Maeshiro T; Awane Y
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1449-51. PubMed ID: 9703851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
    Sugarbaker PH
    Lancet Oncol; 2006 Jan; 7(1):69-76. PubMed ID: 16389186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
    Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of pseudomyxoma peritonei with a pancreatic cancer treated by the intraperitoneal administration of cisplatinum].
    Mitsuhashi T; Murata N; Sobajima J; Okada N; Suzuki T; Ishida H; Hashimoto D; Miura I; Itoyama S
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1670-3. PubMed ID: 11708005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
    Chua TC; Yan TD; Smigielski ME; Zhu KJ; Ng KM; Zhao J; Morris DL
    Ann Surg Oncol; 2009 Jul; 16(7):1903-11. PubMed ID: 19387742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.